Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulse glucocorticoids.

S Sabir1, V P Werth

  • 1Department of Dermatology, University of Pennsylvania, Philadelphia, USA.

Dermatologic Clinics
|August 16, 2000
PubMed
Summary
This summary is machine-generated.

High-dose intravenous methylprednisolone may offer unique therapeutic benefits, potentially reducing long-term glucocorticoid side effects. Further research is needed to confirm its efficacy in dermatologic conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: results of a multicenter, retrospective cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Bullous pemphigoid burden of disease, management and unmet therapeutic needs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Myocardial infarction risk is increased by periodontal pathobionts: a cross-sectional study.

Scientific reports·2022
Same author

Tubal adenocarcinoma in a case report.

International journal of surgery case reports·2022
Same author

Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study.

Journal of the American Academy of Dermatology·2022
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • High-dose intravenous methylprednisolone is used to mitigate long-term glucocorticoid therapy side effects.
  • A perception exists that high-dose intravenous methylprednisolone possesses unique therapeutic properties.

Purpose of the Study:

  • To explore the potential therapeutic effects of high-dose intravenous methylprednisolone in dermatologic conditions.
  • To evaluate the rationale for using this treatment modality in specific patient subsets.

Main Methods:

  • Review of existing literature in neurologic and rheumatologic fields.
  • Analysis of anecdotal reports suggesting efficacy in certain conditions.

Main Results:

  • Evidence from neurologic and rheumatologic fields suggests i.v. methylprednisolone may have distinct effects compared to oral prednisone.

Related Experiment Videos

  • Lack of specific trials in dermatologic disease makes direct extrapolation difficult.
  • Conclusions:

    • While anecdotal reports suggest potential benefits, robust clinical trials are lacking for high-dose intravenous methylprednisolone in dermatology.
    • A rationale exists for considering this therapy in select dermatologic patients based on perceived unique effects.